Jeffrey Lipman's Publications
About Jeffrey Lipman's Publications
Honorary Professorial Fellow-
Prevalence of Augmented Renal Clearance and Performance of Glomerular Filtration Estimates in Indigenous Australian Patients Requiring Intensive Care Admission
Anaesthesia and Intensive Care Date published: -
Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill
Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill Date published: -
Antimicrobial resistance and antibiotic stewardship programs in the ICU: insistence and persistence in the fight against resistance. A position statement from ESICM/ESCMID/WAAAR round table on multi-drug resistance
Intensive Care Medicine Date published: -
Thank you from HMPG and the editors
South African Medical Journal Date published: -
Identifying “at-risk” patients for sub-optimal beta-lactam exposure in critically ill patients with severe infections
Critical Care Date published: -
Using Population Pharmacokinetic Modeling and Monte Carlo Simulations To Determine whether Standard Doses of Piperacillin in Piperacillin-Tazobactam Regimens Are Adequate for the Management of Febrile Neutropenia
Antimicrobial Agents and Chemotherapy Date published: -
Antibiotic Distribution into Cerebrospinal Fluid: Can Dosing Safely Account for Drug and Disease Factors in the Treatment of Ventriculostomy-Associated Infections?
Clinical Pharmacokinetics Date published: -
Maximally effective dosing regimens of meropenem in patients with septic shock
Journal of Antimicrobial Chemotherapy Date published: -
Population Pharmacokinetics of Tigecycline in Critically Ill Patients with Severe Infections
Antimicrobial Agents and Chemotherapy Date published: -
Proposed primary endpoints for use in clinical trials that compare treatment options for bloodstream infection in adults: a consensus definition
Clinical Microbiology and Infection Date published: -
Impact of renal replacement modalities on the clearance of piperacillin-tazobactam administered via continuous infusion in critically ill patients
International Journal of Antimicrobial Agents Date published: -
A validated UHPLC-MS/MS method for the measurement of riluzole in plasma and myocardial tissue samples
Biomedical Chromatography Date published: -
Detailed assessment of benefits and risks of retrievable inferior vena cava filters on patients with complicated injuries: the da Vinci multicentre randomised controlled trial study protocol
BMJ Open Date published: -
Hemoglobin concentrations and RBC transfusion thresholds in patients with acute brain injury: an international survey
Critical Care Date published: -
Comparative total and unbound pharmacokinetics of cefazolin administered by bolus versus continuous infusion in patients undergoing major surgery: a randomized controlled trial
British Journal of Anaesthesia Date published: -
An LC-MS/MS Method to Determine Vancomycin in Plasma (Total and Unbound), Urine and Renal Replacement Therapy Effluent
Bioanalysis Date published: